Position in ESPR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
27,706
+1514.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $277,187,959 across 31 Drug Manufacturers - Specialty & Generic names. ESPR ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
816,187 | $65,074,589 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,468,749 | $60,262,769 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
1,543,944 | $37,996,460 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
3,231,238 | $13,603,511 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
|
3,112,561 | $12,948,253 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
76,569 | $12,904,938 | |
| 7 | ALKS |
Alkermes plc.
|
221,589 | $11,611,263 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,434,433 | $11,360,709 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 27,706 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | — | 1,716 | Shares | Defined | 2026-02-12 | |
| 2020-03-31 | — | 12,900 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||